Abdominal Ultrasound Examination Findings in 534 Hyperthyroid Cats Referred for Radioiodine Treatment between 2007–2010

Nussbaum L.K., Scavelli T.D., Scavelli D.M., et al.

Journal of Veterinary Internal Medicine, 2015. 29(4): p.1069-1073.


Background The prevalence of concurrent disease in hyperthyroid cats is unknown. Objectives To identify the prevalence of concurrent intra-abdominal disease using abdominal ultrasound examination (AUS) in hyperthyroid cats referred for radioactive iodine treatment (RIT) and to determine whether the requirement for pretreatment AUS is justified. Animals Five hundred and thirty-four client-owned cats diagnosed with hyperthyroidism and referred for RIT. Methods Retrospective study. Age, breed, sex, body weight, clinical signs, total serum T4 concentration, blood urea nitrogen (BUN) concentration, serum creatinine concentration, urine specific gravity (USG), AUS results, and biopsy or cytology results, or both (if obtained) were collected from the medical records. Results The prevalence of concurrent disease identified using AUS in hyperthyroid cats referred for RIT was 36.1%; 22.8% of the cats in the study had renal disease and 2.4% had confirmed neoplasia. Significant differences in median USG (P value 0.032) and median BUN (P value 0.028) were found between cats that had abnormal kidneys on AUS compared to those with normal-appearing kidneys. Only 2.2% of the cats were not treated with RIT as a result of changes identified on AUS and subsequently obtained cytology or biopsy results. Conclusions and Clinical Importance The results indicate that pretreatment AUS in hyperthyroid cats referred for RIT is unnecessary in most patients.